This preclinical mouse study investigated the effects of calebin A on diet-induced obesity. It found that calebin A reduced weight gain and blood sugar, improved thermogenesis, and altered gut microbiota composition in mice fed a high-fat diet.
Journal of Traditional and Complementary Medicine · 6 authors, 6 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This preclinical mouse study investigated the effects of calebin A on diet-induced obesity. It found that calebin A reduced weight gain and blood sugar, improved thermogenesis, and altered gut microbiota composition in mice fed a high-fat diet.
This preclinical study used C57BL/6J mice to investigate the anti-obesity effects of calebin A. The study assessed body weight, blood glucose, adipose tissue weights (white, beige, brown), liver weight, rectal temperature during cold exposure, and gut microbiota composition via 16S rRNA sequencing. Results showed that calebin A treatment dose-dependently reduced HFD-induced weight gain and blood glucose levels. It also decreased the weight of various adipose tissues and restored liver weight. In cold exposure tests, calebin A-treated mice maintained higher rectal temperatures, suggesting enhanced thermogenesis. Gut microbiota analysis revealed enrichment of specific commensal bacteria, including *Akkermansia*.